Internal jugular vein thrombosis following ovarian hyperstimulation syndrome

Department of Obstetrics and Gynaecology, St George Hospital, NSW, Australia.
Australian and New Zealand Journal of Obstetrics and Gynaecology (Impact Factor: 1.51). 02/2012; 52(1):87-90. DOI: 10.1111/j.1479-828X.2011.01392.x
Source: PubMed


Two cases of women who developed internal jugular vein (IJV) thrombosis associated with ovarian hyperstimulation syndrome (OHSS) are reported in this article. There are 27 cases of IJV thrombosis associated with in vitro fertilisation (IVF) reported in the literature, and in 78% of cases, this outcome was following OHSS. The hypercoagulable state of OHSS increases the risk of venous thromboembolism, and the IJV appears to have a preponderance in uncommon-site thrombosis.

10 Reads
  • Critical ultrasound journal 12/2011; 3(3). DOI:10.1007/s13089-011-0080-5
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND Compared with the general population, cancer patients have a higher risk of venous thromboembolism as well as arterial thrombotic events such as stroke, myocardial infarction and peripheral arterial embolism. Therefore a possible concern for women with malignancies undergoing ovarian stimulation for fertility preservation is the increased risk of venous or arterial thrombosis.
    Human Reproduction Update 07/2014; 20(6). DOI:10.1093/humupd/dmu035 · 10.17 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this review is to analyse the pathophysiology and complications of thrombosis in conjuction with ovarian hyperstimulation syndrome (OHSS) following ovulation induction and to suggest practical guidelines usefull for the prevention and treatment. Although the incidence of thrombosis varies from 0.2% among in vitro fertilization (IVF) cycles and up to 10% for severe cases of the syndrome, it represents the most dangerous complication of OHSS. Different changes in haemostatic markers have been found to create a state of hypercoagulability, but no single standard test is available to estimate the state of thrombosis. The role of markers for thrombophilia is controversial. Thromboses are mostly venous (67–75%) involving upper limbs and neck, then arterial (25–33%) which are mainly intracerebral. The predominant sites of venous thromboembolism in the upper part of the body may be explained by higher concentrations of estrogens drained through lymphatic ducts from ascites and by compression of rudimentary branchyal cysts. Once early diagnosis is established, it is crucial to use an anticoagulant treatment with heparin proceeded with thromboprophylaxis. However, identification of patients at risk and preventive measures of OHSS are the best means in reducing the risk of thrombosis after ovarian stimulation.
    Gynecological Endocrinology 11/2014; 30(11):764-768. DOI:10.3109/09513590.2014.927858 · 1.33 Impact Factor